StratDeck

Two stocks in Healthcare

CVS Health vs Intuitive Surgical: profit, growth, debt and price compared

Intuitive Surgical is stronger on 3 of 5 figures: profit margin, sales growth and price trend. CVS Health is stronger on 2: price for its expected profit and analysts' view.

Figures as of 18 November 2026SEC EDGARYahoo Finance
Explore CVS Health's storyWhere next ↓

Save both stocks to your watchlist and revisit their latest fundamentals.

CVS Health and Intuitive Surgical side by side
CVS HealthCVSIntuitive SurgicalISRG
Net margin2.6%Stronger: 25.5%
Revenue growth, past year+5.37%Stronger: +21.70%
Debt to equity93.3%—
Forward P/EStronger: 9.3×33.8×
Dividend yield3.27%—
AnalystsStronger: Strong buy · 26Buy · 30
From its 200-day average−7.3%Stronger: −2.6%

Share price over the past year

  • CVS Health+4.4%
  • Intuitive Surgical−23.0%

18 Nov 202518 Nov 2026

CVS Health or Intuitive Surgical: which is stronger?

  • ISRG

    Which is more profitable?

    Intuitive Surgical keeps more of each sale as profit: 25.5% against 2.6%.

  • ISRG

    Which is growing its sales faster?

    Intuitive Surgical is growing its sales faster: +21.70% over the past year, against +5.37%.

  • CVS

    Which costs less for the profit it is expected to make?

    CVS Health costs less for the profit it is expected to make: 9.3× its forward earnings, against 33.8×.

  • Which pays more in dividends?

    CVS Health pays 3.27% a year in dividends for what a share costs, where Intuitive Surgical pays none.

  • CVS

    Which do analysts rate higher?

    Analysts are warmer on CVS Health: Strong buy, against Buy for Intuitive Surgical.

  • ISRG

    Which is in the stronger price trend?

    Intuitive Surgical's price is in the stronger trend: 2.6% below its 200-day average, against 7.3% below.

What each company does

CVSCVS Health

CVS Health Corporation provides health solutions in the United States.

Reports results on 9 February 2027

ISRGIntuitive Surgical

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally.

Reports results on 21 January 2027

This comparison is just the starting point.

Discover opportunities, understand companies and compare investments in one place. See how StratDeck works

Keep researching

Where next

Every US healthcare comparison

Free email

Up to speed in minutes, four times a week

Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.

Early access

Become a StratDeck founding user

Use StratDeck, tell us what's missing, and help decide what we build next.

100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.